Eckert & Ziegler to acquire Analytics Inc.
Ad hoc announcement §15 WpHG Acquisition Eckert & Ziegler to acquire Analytics Inc. Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement.
Berlin, 11 August 2005.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in radioactive components for medical and industrial use, will acquire, through Isotope Products Laboratories, it's California subsidiary, all of shares of Atlanta, Georgia (USA)-based Analytics Inc. ( http://www.analyticsinc.com ), effective 11 August 2005. Analytics' core manufacturing technology is focused on the production of isotopic calibration standards and quality control cross check systems for environmental monitoring and safety assurance in nuclear power plants. In 2004, it achieved sales of approximately $US 3 Million. In the United States the company maintains a strong position in this market, which is related to Eckert & Ziegler's Nuclear Medicine and Industry business. The acquisition of Analytics will be partially financed by a sellers' loan.
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10 13125 Berlin Deutschland
ISIN: DE0005659700
WKN: 565970
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart
End of ad hoc announcement
(c)DGAP 11.08.2005 111444 Aug 05
Berlin, 11 August 2005.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in radioactive components for medical and industrial use, will acquire, through Isotope Products Laboratories, it's California subsidiary, all of shares of Atlanta, Georgia (USA)-based Analytics Inc. ( http://www.analyticsinc.com ), effective 11 August 2005. Analytics' core manufacturing technology is focused on the production of isotopic calibration standards and quality control cross check systems for environmental monitoring and safety assurance in nuclear power plants. In 2004, it achieved sales of approximately $US 3 Million. In the United States the company maintains a strong position in this market, which is related to Eckert & Ziegler's Nuclear Medicine and Industry business. The acquisition of Analytics will be partially financed by a sellers' loan.
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10 13125 Berlin Deutschland
ISIN: DE0005659700
WKN: 565970
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart
End of ad hoc announcement
(c)DGAP 11.08.2005 111444 Aug 05